Refractory Primary Mediastinal Large B-Cell Lymphoma
Also known as: Primary Mediastinal Large B-Cell Lymphoma-Refractory / Refractory Primary Mediastinal Large B-Cell Cell Lymphoma / Refractory, primary Mediastinal Large B-cell Lymphoma / Primary mediastinal large B-cell lymphoma refractory / Large B-cell lymphoma subtype primary mediastinal (Thymic) large B-cell lymphoma refractory
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB09037 | Pembrolizumab | A PD-1 blocking antibody used to treat various types of cancer, including metastatic melanoma, non small-cell lung cancer, cervical cancer, head and neck cancer, and Hodgkin's lymphoma. |
| Drug | Drug Name | Target | Type |
|---|---|---|---|
| DB09037 | Pembrolizumab | Programmed cell death protein 1 | target |
| DB09037 | Pembrolizumab | Programmed cell death 1 ligand 1 | target |
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB00531 | Cyclophosphamide | 1 | Recruiting | 1 |
| DB01073 | Fludarabine | 1 | Recruiting | 1 |
| DB18115 | Golcadomide | 1 | Recruiting | 1 |
| DB16582 | Lisocabtagene maraleucel | 1 | Recruiting | 1 |
| DB00073 | Rituximab | 1 | Recruiting | 1 |
| DB12483 | Copanlisib | 2 | Active Not Recruiting | 1 |
| DB00531 | Cyclophosphamide | 2 | Recruiting | 1 |
| DB01073 | Fludarabine | 2 | Recruiting | 1 |
| DB16371 | Glofitamab | 2 | Active Not Recruiting | 1 |
| DB18115 | Golcadomide | 2 | Not Yet Recruiting | 1 |
| DB18441 | Maplirpacept | 2 | Recruiting | 1 |
| DB09035 | Nivolumab | 2 | Active Not Recruiting | 2 |
| DB08935 | Obinutuzumab | 2 | Active Not Recruiting | 1 |
| DB17116 | Ontorpacept | 2 | Recruiting | 1 |
| DB09037 | Pembrolizumab | 2 | Recruiting | 2 |
| DB11930 | Varlilumab | 2 | Active Not Recruiting | 1 |